Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Observational Registry Study to Evaluate the Use and Safety of LEQEMBI in Routine Clinical Practice

NCT07781345 is registered in ClinicalTrials.gov with Eisai Limited as lead sponsor.

NCT NCT07781345
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07781345 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Observational Registry Study to Evaluate the Use and Safety of LEQEMBI in Routine Clinical Practice
Lead sponsor
Eisai Limited
Phase
Observational
Overall status
Not yet recruiting
Start date
August 31, 2026
Completion date
December 31, 2031
Enrollment
400 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimers disease